Clinical trials for Cancer in United States

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Study ID: NCT06376526

Sponsor

Dickran Kazandjian, MD

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

Study ID: NCT05948826

Sponsor

TORL Biotherapeutics, LLC

Bladder Bank (a Prospective Banking Study)

Study ID: NCT06109857

Sponsor

Mayo Clinic

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Study ID: NCT06482957

Sponsor

Vanderbilt-Ingram Cancer Center

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Study ID: NCT05363657

Sponsor

Careggi Hospital-University

Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma

Study ID: NCT05994157

Sponsor

Y-mAbs Therapeutics

Impact of Intraoperative ICG on Functional Outc in RARP

Study ID: NCT06446648

Sponsor

University of California, Irvine

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Study ID: NCT06726148

Sponsor

Novartis Pharmaceuticals

Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)

Study ID: NCT05752448

Sponsor

Baylor College of Medicine

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

Study ID: NCT03767348

Sponsor

Replimune Inc.